Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zostavax (AMP) vs Zostavax in Herpes Zoster
NCT01505647Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Apr 2012
- Primary completion
- Jul 2012
- Modality
- Live Attenuated Vaccines
01
Overview
A Phase 3 trial of varicella virus vaccine live in herpes zoster (HZ), sponsored by Merck & Co.. Started Apr 2012; status: completed.
02
Drugs
varicella virus vaccine live
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT01505647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01505647.